Chevron vs Marathon Petroleum
CVX and MPC side by side, both in petroleum refining. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CVX and MPC compare
Chevron is the larger company, worth 3.7 times as much as Marathon Petroleum ($465B against $125B).
On earnings, Marathon Petroleum is cheaper: it trades at 15.3× trailing earnings, against 22.6× for Chevron.
Marathon Petroleum grew revenue faster over the last twelve months (15.0% versus 10.2% for Chevron).
Chevron keeps more of each dollar of sales as profit, with a net margin of 9.6% compared with 5.6% at Marathon Petroleum.
Both pay dividends: Chevron yields 3.0% and Marathon Petroleum 0.90%.
Marathon Petroleum scores higher on the StockData Score (16 against 12 for Chevron), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CVX | MPC |
|---|---|---|
| Size and price | ||
| Market cap | $465B | $125B |
| Share price | $235.52 | $444.73 |
| Change, 1 year | 51.9% | 127% |
| Change, 5 years | 105% | 576% |
| Beta (5Y) | 0.38 | 0.51 |
| Employees | 4,645 | 19K |
| StockData Score | ||
| Total score | 12 | 16 (better) |
| Valuation score | 1 | 1 |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 4 (better) |
| Health score | 5 (better) | 4 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 22.6× | 15.3× (better) |
| P/S | 2.2× | 0.8× (better) |
| P/B | 2.5× (better) | 6.5× |
| EV/EBITDA | 8.3× (better) | 9.0× |
| P/FCF | 17.2× | 9.7× (better) |
| FCF yield | 5.8% | 10.3% (better) |
| Fair value | $195.40 | $413.58 |
| Margin of safety | −20.5% | −7.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 10.2% | 15.0% (better) |
| Revenue growth, 5Y average | 14.8% (better) | 13.7% |
| Net income growth (TTM) | 50.1% | 301% (better) |
| EPS growth (TTM) | 34.6% | 331% (better) |
| Profitability | ||
| Gross margin | 45.4% (better) | 12.5% |
| Operating margin | – | 9.2% |
| Net margin | 9.6% (better) | 5.6% |
| FCF margin | 12.5% (better) | 8.4% |
| Return on equity | 12.2% | 47.9% (better) |
| Return on invested capital | – | 26.0% |
| Financial health | ||
| Debt / equity | 0.00 (better) | 1.72 |
| Net debt / EBITDA | −0.17 | 1.44 (better) |
| Interest coverage | – | 8.7× |
| Current ratio | 1.25 (better) | 1.25 |
| Altman Z-score | 3.66 | 3.97 (better) |
| Piotroski F-score | 5 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.0% (better) | 0.90% |
| Payout ratio | 67.3% | 13.6% |
| Years of dividend growth | 6 (better) | 4 |
| Dividend growth, 5Y average | 5.8% | 10.0% (better) |
| Buyback yield | 2.4% | 3.9% (better) |
| Shareholder yield | 5.4% (better) | 4.8% |
| Ownership | ||
| Held by institutions | 74.3% | 78.0% |
| Held by insiders | 0.34% | 0.30% |
| Insider net buying, 12 months | −$637M | −$13.9M (better) |
| Superinvestors holding | 4 (better) | 1 |
| Short interest, % of float | 1.2% | 2.5% |
Go deeper
- CVX stock overview
- CVX income statement
- CVX valuation and score
- MPC stock overview
- MPC income statement
- MPC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.